Sign in
ASRT Stock Price, Chart, Stats & News
Assertio Holdings, Inc.
Save
Assertio Holdings, Inc. (ASRT) does not currently pay a dividend.
151.86M
Market cap
–
Current P/E
56.50x
Forward P/E
ASRT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.19% |
Operating margin | -15.95% |
Pretax margin | -25.22% |
Net margin | -24.85% |
Effective tax rate | -1.45% |
ROA | -11.05% |
ROE | -29.39% |
D/E | 0.42x |
Interest coverage ratio | -6.16x |
ASRT valuation
P/E | – |
P/S | 1.05x |
P/B | 1.32x |
P/CF | -4.42x |
P/FCF | -4.43x |
P/OCF | -4.42x |
PEG | 0.90x |
EV multiple | 7.52x |
About
Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication addresses conditions such as moderate to severe rheumatoid arthritis (including acute flare-ups), ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis.
Similar securities
Based on sector and market capitalization
Report issue